These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2317755)

  • 1. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies.
    Dahlstrøm KK; Chenoufi HL; Daugaard S
    Cancer; 1990 Apr; 65(8):1722-6. PubMed ID: 2317755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management after doxorubicin and epirubicin extravasation.
    Heitmann C; Durmus C; Ingianni G
    J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy.
    Andersson AP; Dahlstrøm KK
    Eur J Cancer; 1993; 29A(12):1712-4. PubMed ID: 8398299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of cutaneous doxorubicin extravasation by rhodamine-filtered fluorescence microscopy.
    Duray PH; Cuono CB; Madri JA
    J Surg Oncol; 1986 Jan; 31(1):21-5. PubMed ID: 3945073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extravasation in intravenous chemotherapy].
    Harwood K; Herrmann R
    Dtsch Med Wochenschr; 1994 Mar; 119(10):359-60. PubMed ID: 8125043
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapsone for the treatment of doxorubicin extravasation injury in the rat.
    Sommer NZ; Bayati S; Neumeister M; Brown RE
    Plast Reconstr Surg; 2002 May; 109(6):2000-5. PubMed ID: 11994605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozone Ameliorates Doxorubicine-Induced Skin Necrosis - results from an animal model.
    Kesik V; Yuksel R; Yigit N; Saldir M; Karabacak E; Erdem G; Babacan O; Gulgun M; Korkmazer N; Bayrak Z
    Int J Low Extrem Wounds; 2016 Sep; 15(3):248-54. PubMed ID: 26286933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of extravasation injuries secondary to doxorubicin.
    Linder RM; Upton J
    Postgrad Med; 1985 Mar; 77(4):105-9, 112, 114. PubMed ID: 3975182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic changes induced in skin by extravasation of doxorubicin (adriamycin).
    Bhawan J; Petry J; Rybak ME
    J Cutan Pathol; 1989 Jun; 16(3):158-63. PubMed ID: 2671070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of epirubicin after severe extravasation in humans.
    Nedomansky J; Haslik W; Pluschnig U; Kornauth C; Deutschmann C; Hacker S; Steger GG; Bartsch R; Mader RM
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):203-209. PubMed ID: 33907881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management after doxorubicin and epirubicin extravasation.
    Fleming A; Butler B; Gault D
    J Hand Surg Br; 1999 Jun; 24(3):390. PubMed ID: 10433467
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the morbidity from extravasation injuries.
    Khan MS; Holmes JD
    Ann Plast Surg; 2002 Jun; 48(6):628-32; discussion 632. PubMed ID: 12055433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
    Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
    Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
    Valencak J; Troch M; Raderer M
    J Natl Cancer Inst; 2007 Jan; 99(2):177-8. PubMed ID: 17228004
    [No Abstract]   [Full Text] [Related]  

  • 17. Conservative approach to the treatment of chemotherapy-induced extravasation.
    Tsavaris NB; Karagiaouris P; Tzannou I; Komitsopoulou P; Bacoyiannis C; Karabellis A; Papanicolaou V; Mylonakis N; Karvounis N; Zoannou A
    J Dermatol Surg Oncol; 1990 Jun; 16(6):519-22. PubMed ID: 2355131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous extravasation injuries: the effectiveness of hyaluronidase in their treatment.
    Laurie SW; Wilson KL; Kernahan DA; Bauer BS; Vistnes LM
    Ann Plast Surg; 1984 Sep; 13(3):191-4. PubMed ID: 6497266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor agents: extravasation, management, and surgical treatment.
    Scuderi N; Onesti MG
    Ann Plast Surg; 1994 Jan; 32(1):39-44. PubMed ID: 8141535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin extravasation injuries.
    Snyderman RK; Krasna MJ
    Plast Reconstr Surg; 1986 Apr; 77(4):683-4. PubMed ID: 3952231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.